Click Here to register $229.00


This message is sent to you by FDA Newswatch

Implementing a Robust and Compliant Change Control Program

Dec 2 2021 - Thursday 90 Min 10:00 AM PST | 01:00 PM EST

Sponsored by ComplianceOnline

Click Here to register $249.00

Click Here to register and receive  recording $529.00

This Change Control training program will discuss regulatory expectations from the FDA, EU and ICH perspective, review all the required components of a thorough change control program; as well as, discuss the elements regarding successful management an effective Change Control system.

Why Should You Attend:

Regulatory agencies require pharmaceutical and medical device companies to have a systematic approach to managing all changes made to a facility, their product or a quality system. Given the fact that changes are inevitable, it is essential that companies have a compliant and effective change control program to ensure that no unnecessary or cGMP non-compliant changes occur.

At the completion of this course, attendees will be able to:

  • Interpret the requirements of the FDA, EU and ICH guidelines regarding compliant Change Control records.
  • Understand all the required components of a thorough Change Control record.
  • Understand all the elements of effective Change Control management:
    • How to develop a cross-functional team to ensure proper evaluation, approval and implementation of proposed changes.
    • Ensure changes do not negatively impact the business or established marketing authorization.
    • How to incorporate a Quality risk based approach to evaluating proposed changes
    • Ensure changes are implemented in a timely manner by effective use of the Change Control Review Board (CCRB) and Quality Metrics

Areas Covered in the Webinar:

Topic 1: Regulatory Guidance Review

  • FDA (CFR)
  • EU (EurdraLex)
  • ICH Q10

Topic 2: Review all Elements of a Change Control Record

  • Discuss the importance of utilizing Subject Matter Experts from multiple functional areas to ensure proper evaluation, approval and implementation of proposed changes.
  • Ensure changes do not negatively impact the business or established marketing authorization.
  • How to incorporate a Quality risk-based approach to evaluating proposed changes
  • Ensure changes are implemented in a timely manner by effective use of the Change Control Review Board (CCRB) and Quality Metrics
  • Understand what steps should be taken post implementation to confirm the objectives were achieved

Instructor Profile:


Kelly Thomas

Vice President, Americas Quality Operations

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.

Utilizing strategic thinking, risk-based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.